Impact of junctional zone adenomyosis on reproductive outcomes after first single embryo transfer with donated oocytes: A retrospective single-center cohort study
other
OA: closed
public-domain-us
Abstract
OBJECTIVE: To evaluate whether junctional zone (JZ) adenomyosis adversely affects assisted reproductive technologies (ART) outcomes in infertile women undergoing their first single embryo transfer (SET) using donor oocytes.
METHODS: This retrospective single-center cohort study was conducted at Instituto Bernabeu (Alicante, Spain). A total of 240 infertile women undergoing their first SET with donor oocytes between December 2021 and June 2024 were included: 120 with isolated JZ adenomyosis diagnosed by two-dimensional (2D)-three-dimensional (3D) transvaginal ultrasound according to morphological uterus sonographic assessment (MUSA) criteria, matched to 120 controls without uterine abnormalities. Primary outcomes were live birth and miscarriage rates. Secondary outcomes included implantation rate and the relationship between adenomyosis severity and reproductive outcomes. Multivariable models were used to adjust for potential confounders.
RESULTS: Women with JZ adenomyosis had significantly lower live birth rates than controls (34.16% vs 50.83%; P = 0.009) and higher miscarriage rates (32.93% vs 11.11%; P < 0.001), while implantation rates were comparable (68.33% vs 75.00%; P = 0.25). JZ adenomyosis independently predicted reduced live birth (odds ratio [OR] 0.43, 95% confidence interval [CI]: 0.24-0.76; P = 0.004) and increased miscarriage risk (OR 3.33, 95% CI: 1.42-7.82; P = 0.005). Increasing disease severity was associated with a higher risk of miscarriage.
CONCLUSION: JZ adenomyosis is associated with significantly lower live birth rates and higher miscarriage rates after a first SET with donor oocytes, despite similar implantation rates. Comprehensive pre-ART ultrasound assessment of the JZ may improve counseling and support targeted strategies to optimize reproductive outcomes.
Full text
2,501 characters
· extracted from
oa-doi-fallback
· 4 sections
· click to expand
Abstract
Objective
To evaluate whether junctional zone (JZ) adenomyosis adversely affects assisted reproductive technologies (ART) outcomes in infertile women undergoing their first single embryo transfer (SET) using donor oocytes.
Methods
This retrospective single-center cohort study was conducted at Instituto Bernabeu (Alicante, Spain). A total of 240 infertile women undergoing their first SET with donor oocytes between December 2021 and June 2024 were included: 120 with isolated JZ adenomyosis diagnosed by two-dimensional (2D)–three-dimensional (3D) transvaginal ultrasound according to morphological uterus sonographic assessment (MUSA) criteria, matched to 120 controls without uterine abnormalities. Primary outcomes were live birth and miscarriage rates. Secondary outcomes included implantation rate and the relationship between adenomyosis severity and reproductive outcomes. Multivariable models were used to adjust for potential confounders.
Results
Women with JZ adenomyosis had significantly lower live birth rates than controls (34.16% vs 50.83%; P = 0.009) and higher miscarriage rates (32.93% vs 11.11%; P < 0.001), while implantation rates were comparable (68.33% vs 75.00%; P = 0.25). JZ adenomyosis independently predicted reduced live birth (odds ratio [OR] 0.43, 95% confidence interval [CI]: 0.24–0.76; P = 0.004) and increased miscarriage risk (OR 3.33, 95% CI: 1.42–7.82; P = 0.005). Increasing disease severity was associated with a higher risk of miscarriage.
Conclusion
JZ adenomyosis is associated with significantly lower live birth rates and higher miscarriage rates after a first SET with donor oocytes, despite similar implantation rates. Comprehensive pre-ART ultrasound assessment of the JZ may improve counseling and support targeted strategies to optimize reproductive outcomes.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflict of interests.
DATA AVAILABILITY STATEMENT
The dataset used and analyzed during the current study is partially available due to data loss that occurred after completion of the analyses. The available data supporting the findings of this study are retained by Dr. Belen Moliner and can be shared upon reasonable request. The results presented in this manuscript are based on the complete dataset as originally collected and analyzed prior to the data loss.
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Outcome instruments
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- pubmed
- last seen: 2026-05-27T00:30:10.426416+00:00
- unpaywall
- last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine